Bezafibrate

CAS No. 41859-67-0

Bezafibrate( Benzofibrate | Bezalip | Bezatrol | BM 15075 | Difaterol )

Catalog No. M14429 CAS No. 41859-67-0

Bezafibrate(BM15075) is the first clinically tested dual and pan-PPAR co-agonism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
50MG 33 In Stock
100MG 47 In Stock
200MG 59 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bezafibrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Bezafibrate(BM15075) is the first clinically tested dual and pan-PPAR co-agonism.
  • Description
    Bezafibrate(BM15075) is the first clinically tested dual and pan-PPAR co-agonism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Benzofibrate | Bezalip | Bezatrol | BM 15075 | Difaterol
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPARα
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    41859-67-0
  • Formula Weight
    361.82
  • Molecular Formula
    C19H20ClNO4
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 18 mg/mL (49.74 mM); DMSO: 72 mg/mL (198.99 mM)
  • SMILES
    ClC1=CC=C(C(NCCC2=CC=C(OC(C)(C)C(O)=O)C=C2)=O)C=C1
  • Chemical Name
    2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tenenbaum A, et al. Cardiovasc Diabetol. 2005 Sep 16;4:14.
molnova catalog
related products
  • 1-Deoxynojirimycin

    1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.

  • GW1929

    GW1929 is a potent PPAR-γ agonist (pKi: 8.84 for human PPAR-γ; pEC50s of 8.56 and 8.27 for human and murine PPAR-γ).

  • Fucosterol

    Fucosterol is isolated from E. stolonifera with anti-diabetic anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression.